EAACI Congress 2024
BackDrug allergy 1
Friday 31 May, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
Anaphylactic shock after rosuvastatin with basophil activation test positive
12:00
Anaphylaxis during chemotherapy: when premedication is the problem
12:00
DON'T GET LABELLED - Betalactamic Allergy labelling in patients admitted to 3rd level hospitals
12:00
Decoding adverse reactions to contrast media: a comprehensive study from Chile
12:00
Desensitization to Natalizumab in a patient with Multiple Slcerosis
12:00
Drug-Induced Enterocolitis Syndrome (DIES) to amoxicillin, confirmed with a lymphocyte transformation test
12:00
Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital
12:00
Integration of beta-lactam allergic evaluation in an antibiotic sterwardship program
12:00
Riddles of drug hypersensitivity diagnosis: a case series
12:00
The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia
12:00
Unveiling the Impact of NSAIDs Hypersensitivity Reactions: A Tertiary Hospital Perspective
